News
-
-
PRESS RELEASE
Exxel Pharma's Innovative Small Molecule, EX937, Rapidly Advancing Toward First-In-Human Study for the Treatment of Refractory Chronic Cough
Exxel Pharma presents its EX937 development program targeting refractory chronic cough, a $11B market need. Phase 1/1b study in normal volunteers starts Q3/4 2025 with unique FAAH inhibition approach -
-
PRESS RELEASE
MicroVision Bolsters Financial Position with Debt Reduction and up to $17 Million in New Capital
MicroVision, Inc. strengthens financial position by raising $17 million in new capital and reducing debt obligations. Focus on industrial customer partnerships and automotive OEM engagements -
-
-
-
PRESS RELEASE
XS Financial Closes Upsized $100 Million Needham Bank-Led Credit Facility with Participation from First Citizens Bank
XS Financial increases credit facility to $100 million with Needham Bank and First Citizens Bank, to fund CAPEX and equipment leases. Gramercy Capital Group advised. First Citizens Bank supports XS' growth in cannabis financing -
PRESS RELEASE
Unusual Machines Enters Into a Definive Agreement to Acquire Drone Software Company Aloft Technologies to Grow the American Drone Ecosystem
Unusual Machines to acquire Aloft Technologies, a leading FAA-approved UAS services provider. Acquisition valued at $14.5M, aimed at strengthening U.S. drone industry -
